|
UBE2L3 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-15 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.12860009805172E-10 |
| Normal-vs-Stage2 |
1.13469999996063E-06 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
1.62770019684899E-10 |
| Stage1-vs-Stage2 |
4.298800E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
7.581800E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
1.749010E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63358215843346E-12 |
| Normal-vs-AfricanAmerican |
5.58589999999359E-05 |
| Normal-vs-Asian |
1.17489999951204E-07 |
| Caucasian-vs-AfricanAmerican |
5.944800E-01 |
| Caucasian-vs-Asian |
8.167000E-01 |
| AfricanAmerican-vs-Asian |
2.876400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.32959976362201E-10 |
| Normal-vs-Female |
9.18900511237553E-11 |
| Male-vs-Female |
8.905800E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.15370000219883E-08 |
| Normal-vs-Extreme_Weight |
4.19340000501478E-08 |
| Normal-vs-Obese |
5.69289999999834E-05 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
5.206200E-01 |
| Normal_Weight-vs-Obese |
2.718800E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
1.225180E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.869220E-01 |
| Normal-vs-Age(41-60Yrs) |
9.06180000037615E-07 |
| Normal-vs-Age(61-80Yrs) |
5.21949150567025E-12 |
| Normal-vs-Age(81-100Yrs) |
2.919200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.525000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.313400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.393600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.362400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.678600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.599400E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
6.821800E-01 |
| Normal-vs-Grade 3 |
4.703800E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
4.752400E-01 |
| Grade 2-vs-Grade 4 |
6.821800E-01 |
| Grade 3-vs-Grade 4 |
4.703800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.10382880192628E-14 |
| Normal-vs-N1 |
5.46440004356441E-10 |
| N0-vs-N1 |
2.190400E-01 |
|
|
